Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.
Saved in:
| Title: | Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply. |
|---|---|
| Authors: | Deanfield J; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK. Electronic address: john.e.deanfield@gmail.com., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Rasmussen S; Novo Nordisk, Søborg, Denmark., Stensen S; Novo Nordisk, Søborg, Denmark., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. |
| Source: | Lancet (London, England) [Lancet] 2026 Apr 25; Vol. 407 (10539), pp. 1601-1602. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-547X |
|---|---|
| DOI: | 10.1016/S0140-6736(26)00706-3 |
